Micro RNA‐4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy

Micro RNA‐4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy

Our previous reports have shown that microRNA‐4651 is a potential early diagnostic and prognostic marker for hepatocellular carcinoma. We aimed to investigate whether microRNA‐4651 modified postoperative adjuvant transarterial chemoembolization (pa‐TACE) to improve the prognosis of hepatocellular ca...

Full description

Bibliographic Details
Main Authors:	Tian‐Qi Zhang, Qun‐Qing Su, Xiao‐Ying Huang, Jin‐Guang Yao, Chao Wang, Qiang Xia, Xi‐Dai Long, Yun Ma
Format:	Article
Language:	English
Published:	Wiley 2018-10-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1245

Similar Items

Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization
by: Zhu GQ, et al.
Published: (2018-12-01)

Effect of postoperative adjuvant transarterial chemoembolization on postoperative survival of patients with liver cancer and related influencing factors for prognosis
by: XING Zhixiang
Published: (2017-12-01)

Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study
by: Huang Q, et al.
Published: (2020-09-01)

Clinical effects and prognosis of stereotactic body radiotherapy combined with transarterial chemoembolization for massive hepatocellular carcinoma
by: Jun Pang, et al.
Published: (2021-03-01)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01)

Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Shiro Miyayama
Published: (2020-10-01)

MicroRNA signatures as predictive biomarkers in transarterial chemoembolization‐treated hepatocellular carcinoma
by: Manal S. Fawzy, et al.
Published: (2021-03-01)

Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy
by: Yue-Lin Zhang, et al.
Published: (2020-09-01)

Ultraselective conventional transarterial chemoembolization: When and how?
by: Shiro Miyayama
Published: (2019-12-01)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020-01-01)

Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.
by: Jonggi Choi, et al.
Published: (2020-01-01)

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient
by: Antonio Orlacchio, M.D., et al.
Published: (2020-12-01)

Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres
by: Waleed M. Hetta, et al.
Published: (2014-09-01)

Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Predictors of Survival
by: Summit Sawhney, et al.
Published: (2011-01-01)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen W, et al.
Published: (2017-10-01)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2017-07-01)

Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: Wang H, et al.
Published: (2020-05-01)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
by: Seong Kyun Na, et al.
Published: (2018-01-01)

A Rare Complication Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Wei-Chen Lin, et al.
Published: (2015-12-01)

Tumor Response Evaluation Transarterial Chemoembolization-treated Hepatocellular Carcinoma
by: Juferdy Kurniawan
Published: (2016-05-01)

Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
by: Hao Hu, et al.
Published: (2014-01-01)

Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study
by: Nomura, Akihiro, et al.
Published: (2020-02-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients
by: In Joon Lee, et al.
Published: (2019-08-01)

Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma
by: Lei Chen, et al.
Published: (2020-06-01)

Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres® Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis
by: Bin Liang, et al.
Published: (2021-03-01)

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
by: Qunfang Zhou, et al.
Published: (2020-11-01)

Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
by: Farina M. Hanif, et al.
Published: (2014-10-01)

Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles
by: Toshiyuki Irie, et al.
Published: (2020-01-01)

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
by: Lv WF, et al.
Published: (2018-10-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
by: Al Fuhaid Turki, et al.
Published: (2007-01-01)

Spontaneous regression of lung metastases after transarterial chemoembolization for hepatocellular carcinoma
by: Naoko Kakuta, MD, et al.
Published: (2021-06-01)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
by: Shuling Chen, et al.
Published: (2019-04-01)

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection.
by: Mi Young Jeon, et al.
Published: (2019-01-01)

Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis.
by: Baek Gyu Jun, et al.
Published: (2018-01-01)

Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials
by: Fan Cheung, et al.
Published: (2013-01-01)

Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus.
by: Xiaohe Yu, et al.
Published: (2014-01-01)

Early alpha-fetoprotein response can predict the prognosis of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization
by: XIA Dongdong, et al.
Published: (2017-06-01)

Treatment of Huge Hepatocellular Carcinoma Using Cinobufacini Injection in Transarterial Chemoembolization: A Retrospective Study
by: Jun Dong, et al.
Published: (2016-01-01)

SPARC Negatively Correlates With Prognosis After Transarterial Chemoembolization and Facilitates Proliferation and Metastasis of Hepatocellular Carcinoma via ERK/MMP Signaling Pathways
by: Yao Liu, et al.
Published: (2020-05-01)